AVILEX PHARMA ApS: Financial statements 2025
CVR: 34896828
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
AVILEX PHARMA ApS (CVR 34896828) has filed annual accounts for 2025. In 2025, the company reported a net result of DKK -4,530,000 compared with DKK -4,428,000 the year before. Equity in the 2025 report amounted to DKK -10,797,000. The company had 2 employees in the financial year.
- Profit/Loss
- DKK -4,530,000
- Equity
- DKK -10,797,000
- Total Assets
- DKK 18,391,000
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | - | -4.5 mio. | -10.8 mio. | 2 |
| 2024 | - | - | -4.4 mio. | -6.3 mio. | 2 |
| 2023 | 0 | 0 | -6.8 mio. | -1.8 mio. | 2 |
| 2022 | 45.5 mio. | 45.5 mio. | 28.6 mio. | 4.9 mio. | 2 |
| 2021 | - | - | -6.6 mio. | -25.3 mio. | 2 |
Official annual report
How creditworthy is AVILEX PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
AVILEX PHARMA ApS has published its annual report for 2024. The net result was DKK -4,428,000.
As of June 6, 2025, Camilla Petrycer Hansen has joined the board of directors of AVILEX PHARMA ApS.
As of June 6, 2025, Morten Døssing has left the board of directors of AVILEX PHARMA ApS.
About AVILEX PHARMA ApS
AVILEX PHARMA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Kristian Strømgaard. The board consists of Raymond George Hill (chair), Camilla Petrycer Hansen, Jonathan Mark Treherne and Kristian Strømgaard. The company's owners include Novo Holdings A/S, MIKAEL SØNDERGÅRD THOMSEN ApS and KRISTIAN STRØMGAARD HOLDING ApS. The company has 4 employees (2025). In 2025, the company reported a net result of DKK -4,530,000 compared with DKK -4,428,000 the year before. Equity in the 2025 report amounted to DKK -10,797,000.